Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
about
The notch ligand JAGGED1 as a target for anti-tumor therapyTargeting Notch to overcome radiation resistanceTargeting cancer stem cells by using the nanoparticlesOvarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.Development of nanoscale approaches for ovarian cancer therapeutics and diagnosticsEpigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer.Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Notch signaling in serous ovarian cancer.Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses.Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.Utilisation of nanoparticle technology in cancer chemoresistance.Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancerOverexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomasIn vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyClinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancermiR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.The role of Notch signalling in ovarian angiogenesis.Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.Role of Notch signalling pathway in cancer and its association with DNA methylation.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Lateral inhibition of Notch signaling in neoplastic cells.TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer.Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activationVersatility of chitosan/BmNPV bacmid DNA nanocomplex as transfection reagent of recombinant protein expression in silkworm larvae.Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.Chitosan Nanoparticles for miRNA Delivery.Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer.Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
P2860
Q21129294-E74451D3-7DA2-48CD-8F8B-B3424E102708Q26771701-CD9FED16-8BD2-47DA-A08E-AD06AE703473Q26783590-63DE7197-238F-469E-A247-D14889EA4002Q26826899-A84B5A93-D99F-4C64-BDDE-586DF4EEC3E5Q30410019-3068B352-E933-4839-9169-0307C40FCF32Q30421664-31CE20CD-941B-4F83-AC6E-E6C6BD55ADE0Q33572313-6ABBCB9D-E77D-4F26-A565-EDDA2481778EQ33654212-A48C8956-AD75-407C-A98A-375058BF0F93Q33851035-31029361-322B-4702-8ED9-E263FC3E8512Q34022694-5B088E84-7255-4AAF-8188-E01FC9C82E2CQ34491211-36B60866-1E22-40A5-A67A-F1D9BCF3529FQ34638089-ED90112F-BBB2-4A9B-B9D8-5101E8AC91A5Q34722352-29798E12-6835-4CFF-9096-0122BE03401CQ36190702-858C94EE-BBED-40D2-8805-22EAAC51919FQ36421258-B5FDA6AA-B338-421B-B3BA-9FFE7B73AB01Q36510958-2E3B01B7-194A-44C5-A16A-4C7CB220484EQ36621195-B424DD9A-DAA1-499A-A521-7AE54E938459Q37465136-20B8E010-E190-45F0-9F4D-146DE0D5F00EQ37585313-F7A5D835-680D-430D-8674-4CF7C624F844Q37681848-AE4F0607-1BE6-4C88-A2D7-B9FC18D7287FQ37694018-57097217-1D87-49BA-A67E-07AF9CED37BEQ38034167-F7F27979-9C76-4170-897A-76283F499422Q38174045-D8183BEB-A5B6-45E0-A40A-F2C83ED4BBAFQ38203882-BF826392-5256-41EE-8B97-3D16410EC4B4Q38923462-9C25108A-042A-4B9D-BD5F-CFCF77C79375Q39071510-ABDE4448-F87F-47CB-8E23-46FA46D84714Q40030601-E0666CD6-C434-4EEA-9C1D-7839CA6E85A3Q40153305-50F185F8-006E-4F67-B2B5-28E1DD35DF77Q41472543-48060C78-C413-4E2F-A9F6-CC96D0C0DE14Q41991594-6552C981-999F-4825-A83B-0D3B89F635CCQ46450905-69ECF31D-C6AF-42D7-9774-51EB6AA7B1AFQ48715887-28B51AA1-6988-4B28-B36F-FA5C00FFE3ECQ55007797-09E41A8E-36FE-4219-B078-1F82CCC301F3Q58781616-6E36FD90-5742-445C-83D1-2C7645438E62
P2860
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@ast
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@en
type
label
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@ast
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@en
prefLabel
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@ast
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@en
P2093
P2860
P1476
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
@en
P2093
Adam D Steg
Alpa M Nick
Anil K Sood
Ashwini A Katre
Blake Goodman
Charles N Landen
Gabriel Lopez-Berestein
Hee-Dong Han
Rebecca L Stone
Robert L Coleman
P2860
P304
P356
10.1158/1078-0432.CCR-11-0432
P407
P577
2011-07-13T00:00:00Z